Viewing Study NCT01016392


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2025-12-27 @ 10:40 AM
Study NCT ID: NCT01016392
Status: COMPLETED
Last Update Posted: 2022-04-15
First Post: 2009-11-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observational Study on the Long Term Safety of KuvanĀ® Treatment in Patients With Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or BH4 Deficiency
Sponsor: BioMarin Pharmaceutical
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module